Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-24Clinical Trial Update: Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges [Phase 2, Phase 3]
The Phase 2/Phase 3 trial evaluating a digital strategy-based educational skills group for secondary students with ADHD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-04Clinical Trial Update: Families, Responsibility, Education, Support, and Health for Executive Function [NA]
Clinical trial NCT05165511 (University of California, San Diego) on overweight/obesity and ADHD was withdrawn; no drug intervention is liste…
-
CLINICAL_TRIALS withdrawal · 2026-01-28Clinical Trial Update: Healing Minds II: Biofeedback, Breathing Practices, Nutrition and Exercise Counseling in Children and Adolescents With ADHD [NA]
The clinical trial NCT07180602 (Healing Minds II) investigating biofeedback, breathing practices, nutrition and exercise counseling for atte…
-
CLINICAL_TRIALS withdrawal · 2025-10-03Clinical Trial Update: ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder [Phase 4]
A Phase 4 clinical trial evaluating ADZENYS XR-ODT in children aged 4 to under 6 with ADHD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-07Clinical Trial Update: Adaptive Response to Intervention (RTI) for Students With ADHD [Phase 4]
A Phase 4 clinical trial evaluating adaptive response-to-intervention for students with Attention-Deficit/Hyperactivity Disorder has been wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-04-15Clinical Trial Update: Helping Toddlers and Parents Together [NA]
A clinical trial sponsored by the University of Maryland, College Park investigating ADHD and parenting has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-03-15Clinical Trial Update: Multimodal Brain Imaging of Methylphenidate in Children and Adolescents With ADHD [Phase 4]
Phase 4 clinical trial investigating multimodal brain imaging of methylphenidate in children and adolescents with ADHD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-12-02Clinical Trial Update: Event Rate and Effects of Stimulants in ADHD [Phase 3]
A Phase 3 ADHD trial was withdrawn, providing no conclusive results for stimulant effects.
-
CLINICAL_TRIALS withdrawal · 2021-11-15Clinical Trial Update: Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population [Phase 3]
Phase 3 trial evaluating melatonin for youth with ADHD and initial insomnia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-07-06Clinical Trial Update: A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators [Phase 3]
Phase 3 trial of SPD465 in young adults with ADHD using driving simulators has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-06-03Clinical Trial Update: Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 trial of SPD489 for ADHD in adolescents aged 13-17 was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-09-18Clinical Trial Update: Classroom Study of SPN-812 in Children With ADHD [Phase 3]
A Phase 3 trial of SPN-812 in children with ADHD was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-11-01Clinical Trial Update: A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD [Phase 4]
A Phase 4 trial evaluating methylphenidate HCl ERCT in 4-5 year old children with ADHD was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-11-01Clinical Trial Update: A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. [Phase 4]
A Phase 4 clinical trial evaluating Quillichew ERCT in 4-5 year old children with ADHD was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-11-01Clinical Trial Update: Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD. [Phase 4]
A Phase 4 safety, tolerability, and pharmacokinetics study of extended-release methylphenidate in 4- to 5-year-olds with ADHD has been withd…
-
CLINICAL_TRIALS withdrawal · 2018-07-13Clinical Trial Update: Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder [NA]
A clinical trial evaluating medication management for Attention-deficit/hyperactivity disorder has been withdrawn. The study identified as N…
-
CLINICAL_TRIALS withdrawal · 2017-11-07Clinical Trial Update: Electroencephalogram and Attention Deficit Hyperactivity Disorder Study
A University of Michigan EEG study investigating Attention Deficit Hyperactivity Disorder with healthy control participants has been withdra…
-
CLINICAL_TRIALS withdrawal · 2017-01-31Clinical Trial Update: Executive Functioning and Mindfulness in Adults With Attention Deficit/Hyperactivity Disorder Imaging [NA]
A clinical trial investigating executive functioning and mindfulness in adults with attention-deficit/hyperactivity disorder has been withdr…
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: Attention Intervention Management [NA]
Clinical trial NCT01779427 evaluating Attention Intervention Management for traumatic brain injury and ADHD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-28Clinical Trial Update: Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging [Phase 4]
A Phase 4 clinical trial investigating whether functional MRI can predict stimulant treatment response in adults with Attention-deficit/hype…
-
CLINICAL_TRIALS withdrawal · 2014-02-26Clinical Trial Update: Effect of Methylphenidate on Connectivity [Phase 4]
Phase 4 trial evaluating methylphenidate on brain connectivity in attention-deficit/hyperactivity disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-24Clinical Trial Update: Memantine Monotherapy for Executive Dysfunction and ADHD [NA]
The clinical trial evaluating memantine monotherapy for ADHD with executive function deficits has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-23Clinical Trial Update: Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder [NA]
A clinical trial evaluating a parent-provider intervention to improve medication adherence in children with ADHD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-05Clinical Trial Update: Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD [Phase 4]
This Phase 4 study evaluating atomoxetine for ADHD in adolescents and young adults with substance use disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-24Clinical Trial Update: Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate [Phase 4]
A Phase 4 clinical trial evaluating OROS methylphenidate for college students with ADHD has been withdrawn.